Ginseng does not enhance psychological well-being in healthy, young adults: Results of a double-blind, placebo-controlled, randomized clinical trial

被引:31
|
作者
Cardinal, BJ [1 ]
Engels, HJ
机构
[1] Oregon State Univ, Dept Exercise & Sport Sci, Corvallis, OR 97331 USA
[2] Wayne State Univ, Div Hlth Phys Educ & Recreat Exercise Sci, Detroit, MI USA
关键词
D O I
10.1016/S0002-8223(01)00165-1
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective Ginseng is a popular, commercially available dietary supplement that is purported to have a number of psychological benefits. The purpose of this study was to examine these claims, with specific reference to ginseng's effects on affect and mood. Design Prospective, double-blind, placebo-controlled, randomized clinical trial, Participants/setting Eighty-three adults (40 women, 43 men) participated in this study (mean age=25.7 year). Participants were recruited from within a university community and at area health clubs. Intervention Participants were randomly assigned to one of three experimental conditions: placebo (lactose), 200 mg ginseng, or 400 mg ginseng. The ginseng preparation used in this study consisted of the Panax ginseng C A Meyer concentrate G115 in capsular format. Each participant was given a 60-day allotment of their respective supplement along with written instructions about the proper intake and storage of the capsules during the 8-week study period. Main outcome measures Positive affect, negative affect, and total mood disturbance. Measures were obtained pre- and post-intervention. Statistical analyses performed Repeated measures multivariate analysis of variance was used. Because there were three dependent variables, and in an effort to minimize the experimentwise-error rate, a was adjusted using the Bonferroni technique (ie, P < .05/3=P < .016). Results Ginseng supplementation had no effect on positive affect, negative affect, or total mood disturbance (all P > .016). Conclusion The present findings do not support claims that chronic ginseng supplementation-at either its clinically recommended level or at twice that level-enhances affect or mood in healthy young adults.
引用
收藏
页码:655 / 660
页数:6
相关论文
共 50 条
  • [31] JinqiJiangtang tablets for prediabetes: A randomized, double-blind and placebo-controlled clinical trial
    Wang, Hui
    Guo, Liping
    Shang, Hongcai
    Ren, Ming
    Wang, Xuemei
    Wang, Dehui
    Chen, Jianzong
    Li, Shuanglei
    Chen, Liming
    Wang, Yue
    Liu, Zhi
    Zhai, Jingbo
    Song, Yuzhen
    Cao, Hongbo
    Zhang, Junhua
    Liu, Chunxiang
    Sun, Xiao
    Huo, Da
    Mu, Wei
    Zhang, Li
    Zheng, Wenke
    Yan, Xiaoyan
    Yao, Chen
    SCIENTIFIC REPORTS, 2017, 7
  • [32] CHOLECALCIFEROL SUPPLEMENTATION AND INFLAMMATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
    Seibert, Eric
    Ulrich, Christof
    Trojanowicz, Bogusz
    Lehmann, Ulrike
    Dierkes, Jutta
    Stangl, Gabriele I.
    Girndt, Matthias
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [33] Immunomodulatory Effects of Saffron: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Kianbakht, S.
    Ghazavi, A.
    PHYTOTHERAPY RESEARCH, 2011, 25 (12) : 1801 - 1805
  • [34] Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial
    Ranasinghe, Priyanga
    Wathurapatha, Wasundara S.
    Galappatthy, Priyadarshani
    Katulanda, Prasad
    Jayawardena, Ranil
    Constantine, Godwin R.
    JOURNAL OF DIABETES, 2018, 10 (05) : 386 - 397
  • [35] A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Of Omalizumab For Chronic Rhinosinusitis
    Mehta, N. J.
    Pinto, J.
    de Tineo, M.
    Baroody, F. M.
    Naclerio, R. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S201 - S201
  • [36] The effects of AG1® supplementation on the gut microbiome of healthy adults: a randomized, double-blind, placebo-controlled clinical trial
    La Monica, Michael B.
    Raub, Betsy
    Hartshorn, Shelley
    Gustat, Ashley L.
    Grdic, Jodi
    Kirby, Trevor O.
    Townsend, Jeremy R.
    Sandrock, Jen
    Ziegenfuss, Tim N.
    JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION, 2024, 21 (01)
  • [37] Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial
    Blom, Kerstin
    Forsell, Erik
    Hellberg, Monica
    Svanborg, Cecilia
    Jernelov, Susanna
    Kaldo, Viktor
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2024, 93 (02) : 100 - 113
  • [38] Salidroside and exercise performance in healthy active young adults - an exploratory, randomized, double-blind, placebo-controlled study
    Schwarz, Neil A.
    Stratton, Matthew T.
    Colquhoun, Ryan J.
    Manganti, Alexia M.
    Sherbourne, Margaux
    Mourey, Florian
    White, Caitlyn C.
    Day, Heather
    Dusseault, Micaela C.
    Hudson, Geoffrey M.
    Vickery, Christopher R.
    Schachner, Holly C.
    Kasprzyk, Philip G.
    Weng, Jing-Ke
    JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION, 2024, 21 (01)
  • [39] Almotriptan is an effective and well-tolerated treatment for migraine pain:: results of a randomized, double-blind, placebo-controlled clinical trial
    Dowson, AJ
    Massiou, H
    Laínez, JM
    Cabarrocas, X
    CEPHALALGIA, 2003, 23 (02) : 453 - 461
  • [40] Almotriptan is an effective and well-tolerated treatment for migraine pain:: results of a randomized, double-blind, placebo-controlled clinical trial
    Dowson, AJ
    Massiou, H
    Laínez, JM
    Cabarrocas, X
    CEPHALALGIA, 2002, 22 (06) : 453 - 461